Evaluation of the substantia nigra by means of transcranial ultrasound imaging;Evaluación de la sustancia negra mediante ultrasonografía transcraneal

Revista de Neurologia

Volumn 56, Issue 5, 2013, Pages 268-274

  Vivó Orti, María Nieves ^a   Tembl, José Ignacio ^a   Sastre Bataller, Isabel ^a   Vázquez Costa, Juan Francisco ^a   Sahuquillo, Patricia ^a   Burguera, Juan Andrés ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Diagnosis; Echogenicity; Movement disorders; Parkinson's disease; Substantia nigra; Transcranial ultrasound imaging

Indexed keywords

ACCURACY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOPPLER ECHOGRAPHY; HUMAN; PARKINSON DISEASE; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SUBSTANTIA NIGRA; AGED; ECHOGRAPHY; FEMALE; MALE; MIDDLE AGED; REFERENCE VALUE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; REFERENCE VALUES; SUBSTANTIA NIGRA; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL;

EID: 84874744993     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.5605.2012638     Document Type: Article

References (30)

1. Koller WC. The diagnosis of Parkinson's disease. Arch Intern Med 1984; 144: 2146-7.
2. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinicopathologic study of 100 cases. J Neurol Neurosurg Psychiatry 1992; 55: 181-4.
3. Jankovic J, Rajput AH, McDermott MP, Perl DP. The evolution of diagnosis in early Parkinson disease. Parkinson Study Group. Arch Neurol 2000; 57: 369-72.
4. Rajput AH, Rozdilsky B, Rajput A. Accuracy of clinical diagnosis in parkinsonism -a prospective study. Can J Neurol Sci 1991; 18: 275-8.
5. Berland LL, Bryan CR, Sekar BC, Moss CN. Sonographic examination of the adult brain. J Clin Ultrasound 1988; 16: 337-45.
6. Walter U, Kanowski M, Kaufmann J, Grossmann A, Benecke R, Niehaus L. Contemporary ultrasound systems allow high-resolution transcranial imaging of small echogenic deep intracranial structures similarly as MRI: a phantom study. Neuroimage 2008; 40: 551-8.
7. Huber H. Transcranial sonography -anatomy. Int Rev Neurobiol 2010; 90: 35-45.
8. Skoloudík D, Walter U. Method and validity of transcranial sonography in movement disorders. Int Rev Neurobiol 2010; 90: 7-34.
9. Becker G, Seufert J, Bogdahn U, Reichmann H, Reiners K. Degeneration of substantia nigra in chronic Parkinson's disease visualized by transcranial color-coded real-time sonography. Neurology 1995; 45: 182-4.
10. Glaser M, Weber U, Hinrichs H, Niehaus L. Neuroimaging of midbrain structures with different phased-array ultrasoundsystems. Klin Neurophysiol 2006; 37: 165-8.
11. Walter U, Behnke S, Eyding J, Niehaus L, Postert T, Seidel G, et al. Transcranial brain parenchyma sonography in movement disorders: state of the art. Ultrasound Med Biol 2007; 33: 15-25.
12. Berg D, Godau J, Walter U. Transcranial sonography in movement disorders. Lancet Neurol 2008; 7: 1044-55.
13. Hernández-Vara J, Rubiera del Fueyo M, Lorenzo-Bosquet C, Castell-Conesa J, Molina-Cateriano CA, Rodríguez FM. Utilidad de la sonografía del parénquima cerebral en la enfermedad de Parkinson: estudio comparativo con 123I-FP-CIT SPECT. Med Clin (Barc) 2008; 131: 285-9.
14. Stockner H, Sojer M, Seppi K, Wenning GK, Schmidauer C, Poewe W. Midbrain sonography in patients with essential tremor. Mov Disord 2007; 22: 414-7.
15. Ressner P, Skoloudik D, Hlustik P, Kanovsky P. Hyperechogenicity of the substantia nigra in Parkinson's disease. J Neuroimaging 2007; 17: 164-7.
16. Huang YW, Jeng JS, Tsai CF, Chen LL, Wu RM. Transcranial imaging of substantia nigra hyperechogenicity in a Taiwanese cohort of Parkinson's disease. Mov Disord 2007; 22: 550-5.
17. Berg D, Siefker C, Becker G. Echogenicity of the substantia nigra in Parkinson's disease and its relation to clinical findings. J Neurol 2001; 248: 684-9.
18. Kolevski G, Petrov I, Petrova V. Transcranial sonography in the evaluation of Parkinson disease. J Ultrasound Med 2007; 26: 509-12.
19. Kim JY, Kim ST, Jeon SH, Lee WY. Midbrain transcranial sonography in Korean patients with Parkinson's disease. Mov Disord 2007; 22: 1922-6.
20. Van de Loo S, Walter U, Behnke S, Hagenah J, Lorenz M, Sitzer M, et al. Reproducibility and diagnostic accuracy of substantia nigra sonography for the diagnosis of Parkinson's disease. J Neurol Neurosurg Psychiatry 2010; 81: 1087-92.
21. Walter U, Wittstock M, Benecke R, Dressler D. Substantia nigra echogenicity is normal in non-extrapyramidal cerebral disorders but increased in Parkinson's disease. J Neural Transm 2002; 109: 191-6.
22. Berg D, Becker G, Zeiler B, Tucha O, Hofmann E, Preier M, et al. Vulnerability of the nigrostriatal system as detected by transcranial ultrasound. Neurology 1999; 53: 1026-31.
23. Berg D, Siefker C, Ruprecht-Dörfler P, Becker G. Relationship of substantia nigra echogenicity and motor function in elderly subjects. Neurology 2001; 56: 13-7.
24. Mehnert S, Reuter I, Schepp K, Maaser P, Stolz E, Kaps M. Transcranial sonography for diagnosis of Parkinson's disease. BMC Neurol 2010; 10: 9.
25. Berg D, Roggendorf W, Schroder U, Klein R, Tatschner T, Benz P, et al. Echogenicity of the substantia nigra: association with increased iron content and marker for susceptibility to nigrostriatal injury. Arch Neurol 2002; 59: 999-1005.
26. Berg D. Disturbance of iron metabolism as a contributing factor to SN hyperechogenicity in Parkinson's disease: implications for idiopathic and monogenetic forms. Neurochem Res 2007; 32: 1646-54.
27. Walter U, Dressler D, Wolters A, Wittstock M, Benecke R. Transcranial brain sonography findings in clinical subgroups of idiopathic Parkinson's disease. Mov Disord 2007; 22: 48-54.
28. Berg D, Merz B, Reiners K, Naumann M, Becker G. Five-year follow-up study of hyperechogenicity of the substantia nigra in Parkinson's disease. Mov Disord 2005; 20: 383-5.
29. De Lau LM, Breteler MM. Epidemiology of Parkinson's disease. Lancet Neurol 2006; 5: 525-35.
30. Fearnley JM, Lees AJ. Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 1991; 114: 2283-301.